Showing results (1-10 of 165) with videos related to
Sort By:
Pageof 17
Toxins|February 29, 2020
Should We Consider the Cardiovascular System While Evaluating CKD-MBD?Merita Rroji, Andreja Figurek, Goce SpasovskiInternational Urology and Nephrology|October 16, 2019
Sclerostin: a new biomarker of CKD-MBDAndreja Figurek, Merita Rroji, Goce SpasovskiCells|February 25, 2023
FGF23 in Chronic Kidney Disease: Bridging the Heart and AnemiaAndreja Figurek, Merita Rroji, Goce SpasovskiDiagnostics (Basel, Switzerland)|March 29, 2023
Proteomic Approaches and Potential Applications in Autosomal Dominant Polycystic Kidney Disease and Fabry DiseaseMerita Rroji, Andreja Figurek, Goce SpasovskiCells|June 2, 2021
The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic MilieuAndreja Figurek, Merita Rroji, Goce SpasovskiExpert Review of Proteomics|August 12, 2024
Advancing kidney transplant outcomes: the role of urinary proteomics in graft function monitoring and rejection detectionMerita Rroji, Andreja Figurek, Goce SpasovskiBiomedicines|March 28, 2025
Targeting Diabetic Atherosclerosis: The Role of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Vascular Protection and Disease ModulationMerita Rroji, Nereida Spahia, Andreja Figurek, et al.International Journal of Molecular Sciences|July 9, 2022
Phosphate in the Context of Cognitive Impairment and Other Neurological Disorders Occurrence in Chronic Kidney DiseaseMerita Rroji, Andreja Figurek, Davide Viggiano, et al.Biomedicines|March 28, 2024
Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney DiseaseMerita Rroji, Goce SpasovskiProteomics|November 11, 2024
Omics Studies in CKD: Diagnostic Opportunities and Therapeutic PotentialMerita Rroji, Goce SpasovskiPageof 17